ABCG2 and cancer: The mechanisms that are involved in MDR include the overexpression of mutispecific ATP-dependent drug efflux pumps, including P-gp, MRP1 and BCRP (ABCG2), which reduce the available concentration of the drug for the cancer cells (19).